This session on the manipulation of T-cell signaling includes fundamental discoveries and cutting-edge clinical advances, says Caitlin Zebley, MD, PhD.

Causal inference techniques are becoming increasingly important as researchers make use of large registry databases, explains Kwang Woo Ahn, PhD.

Experts outline the nuanced dynamics of international research, including the role of health technology assessment and real-world evidence in decision-making, in an opening-day plenary.

Experts including Jill Hollenbach, PhD, MPH, detailed new developments in clinically impactful translational research.

Warren Fingrut, MD, outlined a project to evaluate proactive financial navigation for patients with aplastic anemia.

Stephen Spellman, MBS, previews this session on recent age-focused research that has the potential to guide future studies and decisions in characterizing the optimal suitability of donors.

Jeffery J. Auletta, MD, explains what to expect when members of the ASTCT® and NMDP℠ ACCESS Initiative discuss their work to identify and dismantle access and outcome barriers to HCT and cellular therapy.

The four oral abstract sessions on the agenda for Feb.13 are among more than a dozen oral abstract sessions included in this year’s program.

The pediatric plenary will focus on reducing the toxicity of conditioning regimens and transplant in general without compromising overall survival and event-free survival, said Session Chair Miki Nishitani, MD.

Three experts will discuss the underlying mechanisms of refractory acute graft-versus-host disease that may guide the design of future clinical trials. Victor Tkachev, PhD, shares what to expect.